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ABSTRACT
PURPOSE: The purpose of this study was to compare the effects of a high volume isokinetic
intervention on lower body strength and inflammation, as well as markers of muscle damage in
the subsequent 48 hours between younger and middle-aged men. METHODS: 19 healthy,
recreationally trained men were randomly assigned to two groups, younger adults (YA: 21.8 ±
2.0 y; 90.7 ± 11.6 kg; 21.5 ± 4.1 % body fat), or middle-aged adults (MA: 47.0 ± 4.4 y; 96.0 ±
21.5; 24.8 ± 6.3 % body fat). Both groups reported to the human performance laboratory (HPL)
on four separate occasions. On the first visit (D1), anthropometric assessment, as well as a
familiarization session with the isokinetic dynamometer, was performed. A muscle damaging
protocol (HVP) was performed on the second visit (D2) consisting of 8 sets of 10 repetitions at
60°·sec-1 on the isokinetic dynamometer. An assessment protocol (AP) was performed to assess
performance decrements between the YA and MA groups. For this protocol, a maximal
voluntary isometric contraction (MVIC) was performed, as well as 3 isokinetic kicks at 2
different speeds (240°·sec-1 and 60°·sec-1). For the MVIC, values for peak torque (PKT), average
torque (AVGT), rate of torque development at 100 ms (RTD100), and 200 ms (RTD200) were
recorded. For the isokinetic kicks at 240°·sec-1 (ISK240) and 60°·sec-1 (ISK60), values were also
recorded for peak torque (PKT), average torque (AVGT), as well as peak power (PP), and
average power (AVGP). The AP was performed before the HVP (BL), immediately after the
HVP (IP), 120 minutes after the HVP (120P), as well as one (24H) and two (48H) days
following the HVP. Blood draws were also taken at BL, IP, 24H, and 48H, as well as 30 minutes
(30P), and 60 minutes (60P) following the HVP to assess circulating levels of creatine kinase
(CK), myoglobin (Mb), c-reactive protein (CRP), and interleukin 6 (IL-6). Ultrasound
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assessment was also performed at BL and IP as well to assess changes in muscle morphology as
a result of the intervention. Performance, blood, and ultrasound markers were analyzed using a
repeated measures ANOVA to observe between group comparisons for all of the outcome
variables. RESULTS: There were no group differences observed for isometric or isokinetic peak
torque or average torque, nor were there differences in isokinetic peak power or average power
between the two groups as a result of the intervention. There were, however, differences in the
pattern for rate of torque development at 100 ms and 200 ms between the two groups. RTD 100
was decreased at IP and 48H in YA, with MA showing decreases at IP, but also 120P and 24H
unlike YA. RTD200 was decreased at all time points in YA, while MA was decreased at IP,
24H, and 48H, but not 120P. For markers of muscle damage and inflammation, there were no
differences in the response of Mb, CK, CRP, or IL-6 between groups. CONCLUSIONS: Age
does not appear to be a driving factor in the inflammatory or muscle damage response from a
high volume isokinetic intervention. Though changes in peak torque and average torque from a
high volume isokinetic intervention do not seem to differ between younger and middle-aged
adults, the rate of torque production at 100ms and 200ms is different between groups. This
suggests that while recovery to average or maximal strength after an exercise bout may not be
affected greatly by age, the rate of neuromuscular recovery from exercise may be primarily
affected by other factors such as training status.
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CHAPTER I: INTRODUCTION
Sarcopenia, or the age-related decrease in muscle mass and function, as well as issues
with neuromuscular activation, are significant factors in the decline of quality of life in middleaged and older adults (Janssen et al., 2000; Macaluso et al., 2004). Incorporation of regular
resistance exercise can attenuate age-associated losses in muscle strength and bone mineral
density, as well as enhance immune function, functional capacity, and even increase cognitive
function (Chang et al., 2012; Johnston et al., 2008). While the topics of cognitive function and
bone health are beyond the scope of this work, it is important to note the many beneficial effects
seen from regular resistance exercise throughout life. With roughly only one quarter (~27 %) of
U.S. adults estimated in engaging in recreational resistance exercise, and even less (~10%) for
adults over the age of 50, it can be posited that an increase in this type of training can mitigate or
even eliminate the effects of many debilitating and chronic conditions (Peterson et al., 2011).
The positive effects of resistance exercise are well known and well catalogued, with there
being many benefits, including increased muscle mass and strength, increased bone mineral
density, and even increased insulin sensitivity (Castaneda et al., 2002; Conroy et al., 1993; Ishii
et al., 1998; Skerry et al., 1997; Staron et al., 1994). Though increasing age is a risk factor for
many conditions including osteoporosis, cardiovascular disease, cancer, etc., an individual’s
chronological age and their biological age can differ greatly. Previous research has reported that
age-related decreases in muscle mass, maximal strength and diminished exercise capacity may
be associated with an increase in recovery time from physical activity in older adults (Frontera et
al., 2000; Hunter et al., 2004; Toft et al., 2002). As a result, aged-associated adjustments may be
necessary for the exercise prescription of older adults (>60 y) to allow for appropriate recovery
1

and maximize physiological adaptation from the training program (Candow et al., 2011).
Research has shown enhanced recovery from muscle damage can augment both muscular and
immune function (Frontera et al., 1988; Hunter et al., 2004). In younger adults, performance
following muscle damaging exercise may significantly decrease in comparison to both middleaged and older adults due to higher levels of muscle strength, which may contribute to enhanced
recovery. These greater strength levels in younger adults does not provide much insight into
potential mechanisms for greater recovery patterns in these age groups. In regards to the immune
response between younger and older adults (e.g. > 65 y), a decrease in the magnitude of the
immune response is seen with advanced age (Ceddia et al., 1999; Mazzeo et al., 1998). Only a
limited number of studies have examined recovery from resistance exercise in older adults, but
none that we are aware of in middle-aged (40 – 59 y) individuals. Previously, it has been
demonstrated that the recovery of recreationally trained (3-6 hours of exercise per week) older
adults (~ 69 y) is impaired compared to younger adults (Toft et al., 2002). However, the
mechanism of how these differences occur was not elucidated. Therefore, the purpose of this
study was to examine differences in the recovery and inflammatory response from an acute
resistance exercise session between young (18 – 30 y) and middle-aged (40 – 60) men.
Purposes
1. To compare the effects of a high-volume isokinetic intervention on lower body strength and
inflammatory markers between young and middle-aged men.
2. To compare the effect of a high-volume isokinetic intervention on markers of muscle damage
in 48-hour post-recovery period between young and middle-aged men.
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Hypotheses
It was hypothesized that:
1. An attenuation in the inflammatory and muscle damage response would be shown in
young compared to middle-aged men following a high volume isokinetic training
protocol.
2. An accelerated recovery in strength would be observed in young versus middle-aged men
following the exercise protocol

3

CHAPTER II: REVIEW OF LITERATURE
General Response of the Body from Damaging Exercise
The role of exercise in health is known to be a potent modulator of cardiovascular,
respiratory, immune, and muscle function (Calle & Fernandez, 2010; Kelley & Kelley, 2000;
McArdle et al., 2015; Peterson et al., 2011). The aging process leads to decreased levels of health
and wellness, characterized by decreases in muscle mass, strength, fat free mass, and increases in
time to recovery and chronic disease risk (Fulop et al., 2010; McArdle et al., 2015). Age-related
decreases in muscle mass are referred to as sarcopenia, while age-related decreases in muscle
strength are known as dynapenia (Clark & Manini, 2008). Though there are many potential
mechanisms for the diminished recovery response occurring with age, it is likely due in part to
the role of muscle in the recovery process (Fell et al., 2008). It is posited that both sarcopenia
and dynapenia significantly affect the ability to recover from muscle damage, and while this has
been demonstrated in animal studies, whether or not this relationship occurs in humans is still
unclear (Brooks et al., 1994; Mcbride et al., 1994). Appropriately designed training programs can
improve human performance, improve the quality of life, and attenuate physiological deficits
associated with aging (Baechle et al., 2008; Cartee et al., 2016; Peterson 2010). The mechanisms
associated with these physiological benefits include increasing bone mineral density, increasing
lean body mass, and enhancing immune function, all of which can decrease the risk of disease
and physiological dysfunction (DeSalles et al., 2010; Johnston et al., 2008; McArdle et al.,
2015). The exercise stimulus may result in a degree of acute muscular damage that results in
physiological adaptation (Ebbeling & Clarkson, 1989). The extent of muscle damage can be
quantified by assessing muscle soreness, measuring muscle damage markers in the peripheral
4

circulation, and examining changes in muscle performance. Adaptation is often reported
following an acute protocol as “recovery”, which can be quantified by the duration of time
following exercise-induced muscle damage where performance returns to baseline levels. During
this recovery period following exercise, an individual can experience decreased neuromuscular
and immune function, so reducing time to full recovery can attenuate many of the potential
adverse effects of exercise-induced muscle damage (Byrne & Easton, 2002; Gleeson 2007;
Hakinnen et al., 1993). The importance of the differences within these responses will be further
explicated in the scope of this section. Much of the research focusing on recovery from
resistance exercise has primarily been directed at the endocrine response, or is quantified in
conjunction with ingestion of a nutrient or supplement before or following exercise (Børsheim et
al., 2002; Kraemer et al., 2005; Pasiakos et al., 2014; Rawson et al., 2007). This review of
literature will examine the differences in recovery with respect to neuromuscular and immune
changes between younger and middle-aged populations.
Muscle Damage Markers
After an acute bout of exercise, changes occur in the body’s physiological response,
including increases in inflammatory markers, increases in blood pressure, increases in markers of
muscle damage (i.e. creatine kinase), and increases in circulating myoglobin (Kraemer et al.,
1999; Kraemer et al., 2005; Shaner et al., 2014). These are all dependent upon the amount of
muscle mass utilized, as well as exercise mode, intensity, and volume. Creatine Kinase (CK) is
an intracellular protein found in muscle cells that appears in the blood following disruption of
these cells (Baird et al., 2012; Magal et al., 2010). CK is a generally well-accepted marker of
muscular damage, with increased levels being reported following exercise (Brancaccio et al.,
5

2010). Basal levels of CK vary between individuals, however the relative change in CK
following an acute exercise bout can be used as a marker quantifying the magnitude of muscle
damage resulting from an exercise session (Clarkson et al., 2006). Although the use of CK as a
tool in assessing muscular damage is well acknowledged (Baird et al., 2011; Sayers & Clarkson,
2003), myoglobin (Mb) is also often used to assess muscle damage resulting from exercise
(Brancaccio et al., 2010; Clarkson & Hubal, 2002; Magal et al., 2010). Myoglobin is an oxygen
transporting protein in muscle that allows oxygen to be stored within the muscle, and following
exercise may be released from damaged skeletal tissue into circulation (Clarkson et al., 2006;
Sayers & Clarkson, 2003). Myoglobin is a much smaller protein than CK, and thus is leaked into
the circulation much earlier than CK, providing a first indication of acute muscle damage (Sayers
& Clarkson, 2003). Because CK is a larger protein requiring the assistance of the lymphatic
system to enter circulation, its increase in circulation is delayed. For this reason, Mb is often
used as a marker for the acute-phase muscle damage response, while CK provides a better
measure of the response 24 – 48 hours following exercise (Sayers & Clarkson, 2003). Changes
in CK concentrations typically parallel increases in Mb (Clarkson et al., 2006; Sayers &
Clarkson, 2003).
Immune Response
Changes in the immune response to exercise are dependent upon the metabolic and
mechanical stress of the workout, as well as the training experience of the individual (Gordon et
al., 2012). Increases in inflammatory markers in the circulation following acute exercise initiates
the immune response to the site of muscle damage (Calle & Fernandez, 2010; Gleeson 2007).
Inflammatory markers not only represent the level of muscular damage following exercise, but
6

also have many different roles in the breakdown, repair, and overall recovery process. Interleukin
6 (IL-6) is an inflammatory cytokine that facilitates communication among cells for the
mobilization, proliferation, and differentiation of immune cells to the site of tissue damage (Calle
& Fernandez, 2010). IL-6 has a role as an adipokine (cytokine released from a fat cell) and as a
myokine (cytokine released from a muscle cell) (Pedersen & Febbraio, 2005; Trayhurn et al.,
2010). Its role as an adipokine has been shown to be pro-inflammatory, potentially contributing
to insulin resistance and potentially impeding recovery by modulation of other inflammatory
cytokines (Pedersen & Febbraio, 2005; Trayhurn et al., 2004, 2010). Conversely, its role as a
myokine is considered to be anti-inflammatory, potentially aiding in the recovery process by
inhibiting pro-inflammatory cytokines and stimulating other anti-inflammatory cytokines
(Mathur et al., 2009; Pedersen & Febbraio, 2005). There is a marked increase in IL-6 following
an exercise bout due to the contraction of muscle, and its appearance in the circulation precedes
the appearance of other cytokines in the blood (Febbraio & Pedersen, 2002; Mathur et al., 2009).
Because of this, IL-6 is a common biomarker used to show the degree of inflammation caused by
exercise (Febbraio & Pedersen, 2002).
C-Reactive Protein (CRP) is a protein present in the blood that is associated with the
acute-phase response of inflammation (Du Clos & Mold, 2004). Like IL-6, it is also a marker of
systemic inflammation, and many other cytokines (including IL-6) are thought to play an integral
role in inducing CRP production (Gleeson 2007; Stewart et al., 2007). CRP levels reflect the
circulating levels of IL-6, however CRP increases and decreases more rapidly and dramatically
compared to other inflammatory markers (Du Clos & Mold, 2004). Understanding this,
circulating concentrations of IL-6 and CRP provide an indication of the immune and
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inflammatory processes resulting from exercise (Gleeson, 2007; Stewart et al., 2007). Increases
in both of these biomarkers have been reported following acute exercise, and a faster return to
baseline concentrations may be indicative of an enhanced rate of recovery from damaging
exercise (Clarkson & Hubal, 2002; Gordon et al., 2012). Additionally, elevated basal
concentrations of both CRP and IL-6 have been shown to increase with advancing age, and high
concentrations have also been reported in individuals with lower levels of fitness (decreasing rate
of recovery and increasing disease risk) (Aronson et al., 2004; Bruunsgaard 2002; Kasapis et al.,
2005; Rohde et al., 1999; Toft et al., 2002).
Acute resistance exercise can cause short-term decreases in strength in both untrained and
trained populations, regardless of age (Byrne & Easton, 2002; Clarkson & Hubal, 2002). Though
the time to recovery (i.e. return to baseline strength) is dependent upon many factors (i.e. training
status, age, activity level, etc.), greater degrees of exercise-induced muscle damage incurred
during an acute bout of resistance exercise may lead to significant reductions in strength and
power (Clarkson & Hubal, 2002). As the extent of muscle damage becomes magnified, recovery
processes may be delayed (Byrne et al., 2004).
Effect of Age on the Recovery Response
Previous investigations have illustrated many of the strength and inflammatory changes
that occur following exercise in younger and older populations, with younger populations
showing higher maximal strength and circulating markers of muscle damage during the recovery
period (Kraemer et al., 1999; Smilios et al., 2007; Walker et al., 2014; 2015). Understanding the
recovery response between different age groups may provide a more effective, or appropriate,
exercise prescription. Increasing age is associated with increased disease risk and functional
8

limitations, and decreased muscle mass and strength; these changes together or in part, can
impair the recovery process following exercise (Candow et al., 2005; Miszko et al., 2003;
Peterson et al., 2011). Increased muscle mass and strength changes observed with regular
resistance exercise can enhance recovery from exercise-induced mechanical damage (Brandt &
Pedersen, 2010; Johnston et al., 2007; Kelley & Kelley, 2000; Powers et al., 2014).
Importance of Preserving Muscle Mass
Sarcopenia and dynapenia not only decrease quality of life, but also increase health care
costs, risk of falls, and many other negative consequences (Hunter et al., 2004). Strength
decreases that are associated with age are primarily due to decreases in muscle mass (Frontera et
al., 2000; Volpi et al., 2004). Maximal muscle strength is achieved before the third decade of
life, with rapid declines in muscle strength and function after the fifth decade of life (Hakkinen et
al., 1998; Hunter et al., 2004). Decreases in neuromuscular function seen after this third decade
of life are associated with increases in joint stiffness, as well as a reduction in bone mineral
density (Volpi et al., 2004). Whether this is a result of a detraining effect or early signs of
functional performance loss related to aging is not clear. In any event, decreases in physical
function observed with advancing age can be attenuated or reversed by maintaining or increasing
muscle size and strength (Frontera et al., 1988; Volpi et al., 2004). Because lower body
musculature appears to have greater strength decreases than upper body musculature (Candow et
al., 2011), maintenance of these muscle groups in particular (i.e. legs) becomes essential in
preserving muscle mass, muscle strength, and physical function throughout the course of life
(Candow et al., 2011; Janssen et al., 2000). Twelve weeks of resistance exercise has been shown
to eliminate age-related deficits in elbow flexor, and lower limb strength (Candow et al., 2011).
9

These findings are significant, because they demonstrate that muscle quality, or the capacity of
skeletal tissue to perform is maintained or even increased, with regular low to moderate intensity
resistance exercise, in older adults (Peterson et al., 2011; Silva et al., 2014). The interaction
between these age-related decreases, and the attenuation of said decreases through training may
be the key to understanding the potential changes in recovery from muscle damage throughout
life.
Role of Exercise in Enhancing Muscular and Immune Function
Acute resistance exercise has been shown to substantially increase IL-6 concentrations
post-exercise, while changes in CRP levels appear to be dependent on different factors (i.e.
intensity, duration, and mode of exercise); though reductions of these inflammatory markers
have been reported following chronic training (Kasapis et al., 2005; Mathur et al., 2009; Petersen
et al., 2005). Changes in the concentrations of these immune factors may reflect overall training
stress and may potentially serve as immune markers for training or metabolic disorders (Brandt
& Pedersen, 2010; Gleeson 2007). The risk of overtraining increases with advancing age, with
increased resting concentrations of these immune markers, and an impaired regeneration
response to muscle damage reported in comparison to younger individuals (Mathur et al., 2009;
Stewart et al., 2007; Toft et al., 2002). Though circulating CRP concentrations can be elevated
up to 48-hours post-exercise, regular exercise training can attenuate resting CRP concentrations
and the CRP response post-exercise (Kasapis et al., 2005). In addition, resistance training has
previously been shown to attenuate resting CRP concentration to a greater degree than aerobic
exercise training in sedentary individuals (Donges et al., 2010). Aside from stimulating the
release of CRP, the role of IL-6 is multifactorial, while IL-6 is generally thought of as a pro10

inflammatory cytokine, it has also been reported to act as an anti-inflammatory cytokine when it
is secreted from muscle tissue (Donges et al., 2010; Mathur et al., 2009; Pedersen & Febbraio,
2005). Therefore, increases in IL-6 concentrations and the subsequent increase in other antiinflammatory cytokines such as Interleukin-10 (IL-10) and Interleukin-1 receptor antagonist (IL1RA) following exercise suggests that IL-6 may have a direct role in the recovery process when
secretion is induced by resistance exercise (Brandt & Pedersen, 2010; Mathur et al., 2009;
Petersen et al., 2005). Additionally, lower basal levels of IL-6 and CRP can be achieved through
resistance exercise in both younger and middle-aged populations, increasing their health and
potentially enhancing immune function and recovery (Aronson et al., 2004; Petersen et al., 2005;
Stewart et al., 2007).
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CHAPTER III: METHODOLOGY
Participants
Nineteen recreationally active males were recruited to participate in this parallel designed
study. Study participants were recruited into two groups based on age. The younger-age group
(YA) consisted of men between the ages of 18 –30 while the middle-age group (MA) consisted
of men between the ages of 40 – 59 years. Inclusion criteria required participants to meet the age
requirements of one of the groups and be recreationally active including resistance training for
the previous 6 months prior to enrollment as defined by the American College of Sports
Medicine (150 minutes of exercise/week). All participants were free of any physical limitations
that may have affected performance. Additionally, all participants were free of any medications,
performance-enhancing drugs, nor were they using any dietary supplements as determined by the
health and activity questionnaire. Following an explanation of all procedures, risks and benefits,
each participant provided his informed consent prior to participation in this study. The research
protocol was approved by the Institutional Review Board at UCF prior to participant enrollment.
Study Design
Both groups reported to the Human Performance Laboratory (HPL) on four separate
occasions (Figure 1). On the first visit (D1), participants reported to the HPL following a 2-hour
fast. Anthropometric assessments were performed and included height, weight, and body
composition. Following anthropometric assessment, participants performed a standardized
warm-up. The standardized warm-up consisted of 5 minutes of pedaling on a cycle ergometer at
50 watts. Following the warm-up, participants completed a familiarization protocol on the
isokinetic device. On the second visit (D2), participants arrived 10 hours post-prandial and
12

recorded their subjective levels of pain and soreness on a visual analog scale (VAS). Following
the VAS, participants then provided a baseline blood sample followed by an ultrasound
assessment (US) of their lower body musculature. After the blood sample and US were obtained,
the participants performed the first lower body performance assessment (BL). After a brief fiveminute rest period, participants then completed the high-volume isokinetic protocol (HVP).
Immediately after the HVP (IP), participants again completed the lower body performance
assessment to determine performance decrements resulting from the HVP. Following the IP
measure, VAS and US assessments were performed. Blood samples were collected at 30- (30P),
60- (60P), and 120-minutes (120P) following the HVP. Participants reported to the HPL 24- (D3)
and 48-hours (D4) following D2 for blood, ultrasound, and VAS measures. All blood draws
during D3 and D4 were obtained following a 10-hour fast. The order of assessment, VAS, blood
draw and US measures were consistent for all testing sessions. Participants also performed lower
body performance assessments at D3 and D4.

13

Figure 1. Study Design
On D1, participants were assessed for anthropometric measurement and completed a
familiarization protocol prior to D2. On D2, participants provided blood samples at BL, IP, 30P,
60P, and 120P, ultrasound assessment at BL, IP, and 120P, as well as performance assessment at
BL, IP, and 120 P. The HVP was also performed on this day following the performance
assessment at BL. On D3 and D4, a blood sample, ultrasound assessment, and performance
assessment were collected at 24H and 48H, respectively.
Dietary Recall
All participants provided a 3-day dietary recall beginning the day before D2 testing until
the morning of D4 testing. Participants were asked to maintain their regular diet for the duration
of the investigation. FoodWorks nutrient analysis software (McGraw-Hill, New York, NY, USA)
was used to analyze the self-reported dietary recalls for total kilocalorie intake and macronutrient
distributions (carbohydrate, protein, and fat).

14

Anthropometric Measurements
Body mass (±0.1 kg), and height (±0.1 cm) was measured using a Health-o-meter
Professional scale (Patient Weighing Scale, Model 500 KL, Pelstar, Alsip, IL, USA). Body
composition was assessed using a direct segmental multi-frequency bioelectrical impedance
analyzer (BIA) (InBody 770, Cerritos, CA, USA) according to the manufacturer’s guidelines.
BIA estimates body composition using the conductivity differences of the various tissues due to
its tissue characteristics (water and electrolyte content). This analyzer processes 30 impedance
measurements by using six different frequencies (1, 5, 50, 250, 500, 1000 kHz) at each of five
segments of the body (right arm, left arm, trunk, right leg, left leg) using tetrapolar 8-point tactile
electrodes (Kurinami et al., 2016). Values for total and segmental body fat percentage were then
recorded.
Visual Analog Scales
Participants were instructed to assess their subjective feelings of pain and soreness using
a 100-mm visual analog scale (VAS) (Lee et al. 1991). Participants were asked to rate pain and
soreness intensity by placing a mark on a horizontal 100-mm VAS (Bijur et al. 2001; Nosaka et
al. 2002). No pain or soreness was recorded as 0 and the worst possible soreness or pain as 100.
Evaluations were performed upon arrival to the HPL on D2, D3, D4, and following the HVP on
D2.
Ultrasound Assessment
Non-invasive skeletal muscle ultrasound (US) images were collected from the dominant
thigh, of all participants during all assessment time points. Participants were asked to lay supine
on an examination table with both legs fully extended for a minimum of 5 minutes in order to
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allow fluid shifts to occur (Arroyo et al., 2016). Prior to image collection, all anatomical
locations of interest were identified using standardized landmarks for the rectus femoris (RF),
and vastus lateralis (VL) muscles. The landmarks for the RF and VL were determined along the
longitudinal distance over the femur at 50% of the length of each muscle, respectively. The
length of the RF was defined as the length between the anterior, inferior suprailiac crest and the
proximal border of the patella, while the length of the VL encompassed the distance from the
lateral condyle of the tibia to the most prominent point of the greater trochanter of the femur. The
VL measurement required the participant to lay on their side. Pennation angle (PA), muscle
thickness (MT), cross-sectional area (CSA), and echo-intensity (EI) were all measurements
obtained from the US. All measures were obtained by passing a 12MHz probe (General Electric
LOGIQ P5, Wauwatosa, WI, USA) coated with water-soluble transmission gel (Aquasonic®
100, Parker Laboratories, Inc., Fairfield, NJ) over the surface of the thigh at the predetermined
anatomical locations outlined above. Measures of CSA, PA, and MT were captured using Bmode ultrasonography with gain set at 50 and dynamic range set to 72 to optimize spatial
resolution. Image depth was fixed at 5 cm4. Further analysis of all ultrasound images was
performed via ImageJ (National Institutes of Health, USA, version 1.45s) to quantify CSA, PA,
MT, and EI. Fascicle length (FL) was estimated using the following equation:
FL = MT / sin(PA) (Kawakami, 1995)
Echo-intensity (EI) was quantified through grayscale analysis using the standard histogram
function in ImageJ. The same investigator performed all ultrasound measurements. Intraclass
correlation coefficients and minimal differences (MD) for the VL were as follows: cross-
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sectional area (R = 0.99; MD = 0.85 cm2), muscle thickness (R = 0.97; MD = 0.09 cm), fascicle
length (R = 0.96; MD = 0.45 cm), pennation angle (R = 0.98; MD = 0.68˚), and echo-intensity (R
= 0.99; MD = 1.46 au). Intraclass correlation coefficients and minimal differences (MD) for the
RF were as follows: cross-sectional area (R = 0.96; MD = 0.78 cm2), muscle thickness (R = 0.94;
MD = 0.21 cm), fascicle length (R = .95; MD = .38 cm), pennation angle (R = 0.91; MD =
1.32˚), and echo-intensity (R = 0.94; MD = 3.88 au).
Isokinetic Assessment Protocol
On D2 following the warm-up, participants were seated in the isokinetic dynamometer
(S4, Biodex Medical System, Inc., New York, NY, USA), positioned with a hip angle of 110°
and strapped into the chair at the waist, shoulders, and across the thigh. Chair and dynamometer
settings were adjusted for each participant to correctly align the axis of rotation with the lateral
condyle of the femur. All participants were tested on their right leg, which was secured to the
dynamometer arm just above the medial and lateral malleoli. Isokinetic dynamometer settings for
each individual were recorded and remained consistent throughout the study. The isokinetic
assessment protocol was performed ~10 minutes following the initial US of the participant.
Following the initial isokinetic assessment protocol, the participant remained seated, and a HVP
was performed. For the HVP, the lever arm of the dynamometer was programmed to extend the
participant’s leg to 155 degrees of knee flexion (where 180 degrees is full extension), and flex
the participant’s leg to 95 degrees of flexion. This protocol consisted of 8 sets of 10 repetitions
with concentric knee extension, and eccentric knee flexion at 60 degrees per second. Participants
were instructed to give maximal effort throughout the HVP; verbal encouragement was provided.
For all participants, the right leg was used for the HVP. Following the HVP, another isokinetic
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assessment protocol was performed (IP) in order to quantify the performance decrements of the
participant. Isokinetic assessment protocols were also performed 24 hours (24H), and 48 hours
(48H) after the HVP. The lever arm of the dynamometer was programmed to extend the
participant’s leg to 155 degrees of knee flexion (where 180 degrees is full extension), and flex
the participant’s leg to 95 degrees of flexion. The isokinetic assessment protocol at each time
point consisted of: (i) two maximal voluntary isometric contractions (MVIC’s) at a 70 degree
angle, (ii) one set of 3 repetitions of concentric knee extension at 240 degrees per second and
concentric knee flexion at 60 degrees per second, (iii) one set of 3 repetitions of concentric knee
extension at 180 degrees per second and concentric knee flexion at 60 degrees per second, (iv)
one set of 3 repetitions of concentric knee extension at 60 degrees per second and concentric
knee flexion at 60 degrees per second, and (v) one set of 10 repetitions of concentric knee
extension at 60 degrees per second and eccentric knee flexion at 60 degrees per second. A
familiarization of this protocol was performed following anthropometric measurement on D1 in
order to acquaint the participant with the isokinetic dynamometer. Work performed in each set
was calculated as the product of the mean power of each kick over the time to complete the kick.
Total work done (TWD) was calculated as the sum of the work performed in each of the 8 sets of
ten repetitions during the HVP.
Blood Measurements
Blood samples were obtained at seven time points throughout the study (BL, IP, 30P,
60P, 120P, 24H, and 48H). The BL, IP, 30P, 60P and 120P blood samples were obtained using a
Teflon cannula placed in a superficial forearm vein using a three-way stopcock with a male luer
lock adapter and a plastic syringe. The cannula was maintained patent using a non-heparinized
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isotonic saline solution (Becton Dickinson, Franklin Lakes, NJ, USA). All blood samples were
obtained following a 15-minute equilibration period. The remaining time points (24H and 48H)
were obtained by a single-use disposable needle with the subject in a supine position also for at
least 15 minutes prior to sampling.
Whole blood was collected at each time-point in two 10 mL Vacutainer® tubes (Becton
Dickinson, Franklin Lakes, NJ) for a total of 20 mL. One containing K2EDTA, which is an
anticoagulant to prevent the blood from clotting, and a serum tube containing no anti-clotting
agents. An aliquot of whole blood from the EDTA tube was immediately utilized to assess
hematocrit, hemoglobin, and red blood cell count using a complete blood cell counter (Coulter®
AC-T diff 2™ hematology analyzer). Blood in the serum tube was allowed to clot at room
temperature and subsequently centrifuged at 4,000g for 15 minutes. The resulting serum was
placed into separate 1.8-mL microcentrifuge tubes and frozen at -80° C for later analysis.
Biochemical Analyses
Serum Concentrations of Creatine Kinase (CK) were analyzed with the use of a
commercially available kinetic assay kit (Sekisui Diagnostics, Charlottetown, PE, Canada), per
manufacturer’s instructions. CRP, IL-6, and myoglobin concentrations were obtained via
enzyme-linked immunosorbent assays (ELISA) (Calbiotech, Spring Valley, CA, USA). To
eliminate inter-assay variability, all samples for a particular assay were thawed once, and
analyzed by the same technician using a BioTek Eon spectrophotometer (BioTek, Winooski,
VT). All samples were analyzed in duplicate with a mean coefficient of variation of 4.50% for
CK, 7.38% for CRP, 3.55% for IL-6, and 5.03 % for myoglobin. All biochemical assays were
run per the manufacturer’s instructions.
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Statistical Procedures
Changes in subjective levels of pain and soreness, markers of inflammation and muscle
damage, as well as performance measures, were analyzed via repeated measures analysis of
variance (ANOVA). In addition, changes (∆) in isometric and isokinetic performance from
baseline were analyzed via repeated measures ANOVA. In the event of a significant F value,
LSD post-hoc tests were used for pairwise comparison. Baseline performance comparisons of
both groups were determined by independent t-tests. Outliers were identified when values
exceeded 1.5 times the interquartile range (Barbato et al. 2011). For all analyses, a criterion
alpha level of α ≤ 0.05 was used to determine statistical significance, and statistical software
(SPSS V.21.0, Chicago, IL, USA) was used. All data are reported as mean ± standard deviation.
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CHAPTER IV: RESULTS
Nineteen men volunteered to participate in this investigation. Nine men were in the
younger group (YA), while the other ten were in the middle-aged group (MA). Groups were
significantly different in age (F = 7.969; p < 0.001); however, there were no significant
differences observed in height (F = 3.112; p = 0.390), body mass (F = 1.111; p = 0.559), or body
fat percentage (F = 0.255; p = 0.242). Descriptive data for each group are depicted in Table 1.
There were also no differences in TWD (F= 0.882; p = 0.832) during the isokinetic exercise
protocol between the two groups.
Table 1. Participant Anthropometrics
Age (y)
Height (cm)
Body Mass (kg)
Body Fat (%)

Younger (n = 9)
21.8 ± 2.2
179.5 ± 4.9
91.2 ± 12.2
21.8 ± 4.3

Middle-Aged (n = 10)
47.0 ± 4.4
176.8 ± 7.6
96.0 ± 21.5
24.8 ± 6.3

No differences in average daily caloric (F = 0.137; p = 0.685), carbohydrate (F = 0.009; p
= 0.890), protein (F = 2.481; p = 0.337), or fat intakes (F = .154; p = 0.857) were observed
between YA and MA during the three-day study period. Details of nutrient intake for both
groups can be observed in Table 2.
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Table 2. Average Daily Nutrient Intake
Younger

Middle-Aged

2076.2 ± 545.2

1975.3 ± 520.4

Carbohydrate (g)

220.3 ± 70.2

224.8 ± 69.1

Protein (g)

110.2 ± 43.8

94.8 ± 21.6

Fat (g)

76.0 ± 27.4

78.6 ± 32.9

Calories (kcal)

Performance Measures
Isometric Assessment
Isometric performance measurements can be observed in Table 3, and changes in PKT
are depicted in Figure 2. No significant group x time interactions were observed for PKT (F
=1.928; p = 0.116) or AVGT (F = 1.712; p = 0.158). Significant main effects for time were
observed for both PKT (F = 17.574; p < 0.001) and AVGT (F = 15.345; p < 0.001). PKT and
AVGT at IP, 120P, 24H, and 48H were all significantly lower (p < 0.001) than BL. Baseline
differences were observed for AVGT (p =0.043), and a trend was observed in PKT (F = 0.692; p
= 0.057). However, there were no group x time interactions in ∆ change observed for PKT (F =
2.033; p = 0.146), or AVGT (F = 1.096; p = 0.359).
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Table 3. Isometric Performance Measures.
BL
Peak Torque
(Nm)
YA
MA
Average Torque
(Nm)
YA
MA
Rate of Torque
Development
at 100 ms (Nm/s)
YA
MA
Rate of Torque
Development
at 200 ms (Nm/s)
YA
MA

IP

Time Points
120P

24H

48H

296 ± 44
248 ± 57

193 ± 41
190 ± 48

240 ± 50
214 ± 39

260 ± 48
218 ± 43

260 ± 49
214 ± 52

229 ± 36
188 ± 46

147 ± 32
146 ± 35

180 ± 35
160 ± 30

188 ± 37
169 ± 36

190 ± 34
161 ± 43

1320 ± 370
1170 ± 421

599 ± 225
770 ± 325

1117 ± 446
953 ± 336

1063 ± 459
908 ± 374

790 ± 324
964 ± 413

980 ± 214
726 ± 260

465 ± 111
573 ± 197

777 ± 185
622 ± 144

668 ± 207
532 ± 165

579 ± 93
549 ± 266
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Figure 2. Comparisons of PKT response from Isometric Performance Assessment.
All data are reported as mean ± SD.
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300
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YA
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IP

120P
Time Point

24H

48H

Figure 3. Comparisons of AVGT response from Isometric Performance Assessment.
All data are reported as mean ± SD.

A significant interaction was observed for rate of torque development at both 100 ms (RTD100)
(F = 3.408; p = 0.013), and 200 ms (RTD200) (F = 5.772; p < .001). RTD100 values at IP and
48H were significantly reduced (p < 0.001) compared to BL in YA, while significantly lower
from BL at IP (p = 0.001), 120P (p = 0.023), and 24H (p = 0.011) in MA. For RTD200, values at
IP (p < 0.001), 120P (p = 0.001), 24H (p = 0.004), and 48H (p = 0.001) were significantly lower
than BL in the YA group, while RTD200 was significantly lower from BL at IP (p = 0.015), 24H
(p = 0.002), and 48H (p = 0.021) in the MA group. No between group differences were observed
at any time point for RTD100. However, RTD200 was significantly greater (p = 0.033) for YA
than MA at BL. A group x time interaction in ∆ change was observed for both RTD100 (F =
4.249; p = 0.009) and RTD200 (F = 4.859; p = 0.005). The ∆ change from BL was significantly
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greater for YA than MA in RTD100 at IP (p = 0.033) and 48H (p = 0.044), while the ∆ from BL
at RTD200 was significantly greater for YA than MA change at IP (p = 0.001) and 48H (p =
0.037) as well. Changes in RTD100 are depicted in Figure 4, while changes in RTD200 are
depicted in Figure 5.
1800
1600

RTD100 (Nm/s)

1400
1200
1000
800

YA

600

MA

400
200
0
BL

IP

120P
Time Point

24H

Figure 4. Differences in RTD100 between YA group and MA group.
All data are reported as mean ± SD
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48H

1400
1200

*

RTD200 (Nm/s)

1000
800
YA

600

MA
400
200
0
BL

IP

120P
Time Point

24H

48H

Figure 5. Differences in RTD200 between YA group and MA group
* = Asterisk represents a significant difference in RTD200 between groups. All data are reported
as mean ± SD.

Isokinetic Assessment
No significant group x time interactions were observed for PKT at either 240°·sec-1 (F =
1.756; p = 0.174) or 60°·sec-1 (F = 1.928; p = 0.137). Significant main effects for time were
observed for PKT at both 240°·sec-1 (F = 10.444; p < 0.001) and 60°·sec-1 (F =15.629; p <
0.001). PKT was significantly lower at IP (p < 0.001), 120P (p =0.007), and 24H (p = 0.032)
compared to BL at 240°·sec-1, and significantly lower than BL at IP (p < 0.001), 120P (p <
0.001), 24H (p < 0.001), and 48H (p = 0.002) at 60°·sec-1. Though no baseline differences were
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found for PKT at either 240°·sec-1 (F = 0.081; p = 0.061) or 60°·sec-1 (F = 1.562; p = 0.083),
trends were observed for both measures.
No significant group x time interactions were observed for AVGT at 240°·sec-1 (F =
1.837; p = 0.160) or 60°·sec-1 (F = 2.371; p = 0.086). Significant main effects for time were
noted in AVGT at both 240°·sec-1 (F = 12.494; p < 0.001) and 60°·sec-1 (F =16.425; p < 0.001).
AVGT values at IP (p < 0.001), 120P (p = 0.002), 24H (p = 0.013), and 48H (p = 0.036) were all
significantly lower than BL at 240°·sec-1, and significantly lower at IP (p < 0.001), 120P (p <
0.001), 24H (p < 0.001), and 48H (p = 0.001) compared to BL at 60°·sec-1. There were no
baseline differences found for AVGT at either 240°·sec-1 (F = 0.008; p = 0.094) or 60°·sec-1 (F =
0.940; p = 0.148), though a trend was observed for AVGT at 240°·sec-1. There were no group x
time interactions of ∆ change observed for PKT at 240°·sec-1 (F = 2.937; p = 0.070), PKT at
60°·sec-1 (F = 2.410; p = 0.101), AVGT at 240°·sec-1 (F = 2.665; p = 0.092), or AVGT at
60°·sec-1 (F = 2.796; p = 0.069). All isokinetic performance measurements are depicted in Table
4.
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Table 4. Isokinetic Performance Measures.
BL
Peak Torque at
240°·sec-1
(Nm/s)
YA

151 ± 23

MA

129 ± 24

Average Torque
at 240°·sec-1
(Nm/s)
YA

136 ± 26

MA

115 ± 26

Peak Torque at
60°·sec-1
(Nm/s)
YA

234 ± 28

MA

205± 39

Average Torque
at 60°·sec-1
(Nm/s)
YA

187 ± 30

Time Points
IP
120P

24H

48H

112 ± 36
*
103 ± 20
*

134 ± 33
*
117 ± 23
*

136 ± 39
*
118 ± 18
*

145 ± 39

92 ± 32
*
90 ± 20
*

115 ± 30
*
101 ± 25
*

119 ± 35
*
104 ± 20
*

125 ± 36
*
98 ± 24
*

157 ± 46
*
161 ± 25
*

196 ± 40
*
172 ± 29
*

197 ± 36
*
169 ± 32
*

207 ± 33
*
171 ± 52
*

113 ± 41
*
MA
164 ± 36
121 ± 27
*
* =significantly different than BL.

154 ± 32
*
138 ± 33
*

159 ± 32
*
130 ± 32
*

166 ± 24
*
133 ± 47
*

110 ± 23

Blood Analyses
No significant group x time interactions were observed for myoglobin (Mb) (F = 0.307; p
= 0.640), creatine kinase (CK) (F = 0.607; p = 0.551), C-reactive protein (CRP) (F = 0.320; p =
0.602), or IL-6 (F = 0.466; p = 0.589). However, significant main effects for time were observed
for Mb (F = 8.708; p = 0.005) and CK (F = 8.127; p =0.001). Mb was significantly higher at 30P
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(p = 0.002), 60P (p = 0.001), and 120P (p = 0.007) compared to BL, while CK concentrations at
24H (p = 0.002) and 48H (p = 0.006) were significantly higher than BL. Although no significant
main effect for time was observed for CRP (F = 3.042; p = 0.097), a trend was noted for IL-6 (F
= 3.689; p =0.052). Changes in Mb concentrations are pictured in Figure 4, while changes in CK
concentrations, CRP concentrations, and IL-6 concentrations are pictured in Figures 5, 6, and 7,
respectively.

*
*
*

Figure 6. Changes in Mb concentration.
* = significant difference compared to BL for both YA and MA combined. All data are reported
mean ± SD.
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*

*

Figure 7. Changes in CK concentration.
* = significant difference compared to BL for both YA and MA combined. All data are reported
mean ± SD.
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Figure 8. Changes in CRP concentration.
All data are reported mean ± SD.
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Figure 9. Changes in IL-6 concentration.
All data are reported mean ± SD.

Visual Analog Scales
No significant group x time interactions were observed for subjective measures of pain (F
= 0.102; p = 0.959) or soreness (F = 0.886; p = 0.455). No significant main effect for time was
observed for subjective levels of pain (F = 1.085; p = 0.351), however a significant main effect
for time was observed for subjective levels of muscle soreness (F = 7.319; p = < 0.001). Muscle
soreness was significantly higher at 30P (p = 0.001), 24H (p = .001) and 48H (p = .002)
compared to BL. VAS values for each group are depicted in Table 5.
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Table 5. Average Levels of Subjective Pain and Soreness
BL
VAS for Pain
(cm)
YA
MA
VAS for Soreness
(cm)
YA

0.06 ± 0.19
0.17 ± 0.52

Time Points
30P

0.072 ± 1.53
0.54 ± 1.54

24H

48H

0.070 ± 1.16
0.50 ± .68

0.076 ± 1.97
0.64 ± 1.05

0.25 ± 0.53

3.31 ± 2.10
2.78 ± 2.55
2.67 ± 2.75
*
*
*
MA
0.08 ± 0.25
1.76 ± 2.64
1.97 ± 1.83
3.23 ± 3.23
*
*
*
* = significant difference compared to BL for both YA and MA combined. All data are reported
mean ± SD.

Ultrasound Assessment
No significant group x time interactions were observed for muscle CSA (F= 0.246; p
0.747), or MT (F= 0.687; p = 0.530). However, a main effect for time was observed for both
CSA (F= 13.460; p < 0.001) and MT (F= 3.685; p 0.028). Muscle CSA and MT were
significantly greater at IP (p < 0.001) compared to BL. CSA and MT are depicted for each group
in Table 6.
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Table 6. Muscle Morphology Characteristics
BL

Time Points
IP

120P

24H

48H

34.1 ± 5.6

34.8 ± 6.2

34.4 ± 5.9

31.8 ± 5.6

31.9 ± 5.7

31.5 ± 5.5

2.0 ± 0.4
1.8 ± 0.3
1.9 ± 0.5
*
MA 1.5 ± 0.3
1.8 ± 0.2
1.7 ± 0.2
1.6 ± 0.4
*
*=significant different from BL. All data are reported as mean ±SD.

1.8 ± 0.4

2

CSA (cm )
YA 34.2 ± 6.0
MA 32.1 ± 6.5

37.5 ± 5.2
*
34.7 ± 7.4
*

MT (cm)
YA

1.8 ± 0.4
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1.6 ± 0.4

CHAPTER V: DISCUSSION
This investigation sought to compare changes in neuromuscular performance, muscle
damage, and inflammation between young and middle-aged adults on recovery from a fatiguing
isokinetic exercise protocol. In this investigation, there were no baseline differences in the
height, body mass, body fat percentage, average daily caloric intake, or average daily nutrient
intake between the two groups. There was also no difference in muscle size or thickness between
the groups. In regards to muscular performance, there were no baseline difference in isometric or
isokinetic peak torque, isokinetic average torque, or total work between the groups. There were
baseline differences in isometric average torque, and the rate of torque development at 200 ms.
Also at baseline, a trend towards a difference was observed for isometric peak torque, isokinetic
peak torque (at both 240°·sec -1 and 60°·sec -1), and isokinetic average torque at 240°·sec -1.
Results of the study indicated that although both groups experienced significant performance
decrements, no between-group differences were observed between the younger and middle-aged
participants for these measures. Furthermore, no differences between the groups were observed
in the inflammatory or muscle damage response.
Decreases in muscle mass, function, and neuromuscular activation are major contributors
to the decrease in quality of life for adults (Janssen et al., 2000; Kamen et al., 1995). The amount
of force a muscle can generate, how long it can generate optimal force, and how quickly it can
generate this force, are all vital in assessing the quality of muscle, and its effect on health and
activity. The benefits of resistance training (e.g. increased muscle size and function) can be
observed in both younger adults, as well as older adults (Hakkinen et al., 1998; Walker et al.,
2014).
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Peak torque is a measure of the maximal performance capability of an individual.
Previous investigations examining the effect of age on isokinetic performance have reported
significantly greater peak torque in younger adults (means ranging from 23 - 29 y) compared to
older adults (mean ranging from 60 – 65 y), Candow et al., 2005; Hakkinen et al., 1998; Lynch et
al., 1999). Similar differences in muscular performance have also been observed when
comparing middle-aged (41 – 42 y) and older adults (70 – 72 y) (Hakkinen et al., 1998; 2000).
Evidence from these investigations indicate that there are age-related decreases in muscle
performance (e.g. power, and rate of force development). In contrast to these studies, baseline
differences were found in average torque, and in the rate of torque development at 200 ms, with
only a trend observed in peak torque. As previously discussed, trends were also found in
isokinetic peak torque (at 240°·sec-1 and 60°·sec-1), and average torque at 240°·sec-1 between the
two groups at baseline. It should also be noted that all of the aforementioned studies included
participants who were untrained or novice to resistance exercise. In addition, the population
comparison performed in this investigation was unique, in which this appears to be the first study
to compare young to middle-aged adults with recreational resistance training experience. The
results of this study also indicate that recovery of peak torque from fatiguing exercise appears to
be similar between middle-aged and young adults with recreational resistance training
experience. Whether this is a function of this age group or training status is not clear, but the data
does appear to suggest that recreational training does maintain recovery capability from high
volume isokinetic resistance exercise.
There were no differences in peak or mean torque between groups during the recovery
period. There were also no differences between these groups in ∆ change from BL for these
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variables. Differences in the pattern of recovery between the groups were noted in the rate of
torque development. YA experienced a significantly greater ∆ change between BL and IP, and
between BL and 48H for both RTD100 and RTD200. YA experienced a 52.6% decrease from
BL to IP during RTD100 and a 50.6% decrease in RTD200. In contrast, MA experienced a
31.4% and an 18.3% reduction for RTD100 and RTD200, respectively. The results of this
investigation are in agreement with other studies that have reported decreases in force and the
rate of force development with increasing age (Hakkinen et al., 1998; Izquierdo et al., 1999;
Thompson et al., 2014). It appears that the rate of force development declines at a greater rate
than muscle performance with increasing age. This provides a potential explanation for the
differences observed in the rate force development between the groups at baseline, as well as
differences in the rate of torque development at 100 ms and 200 ms during the recovery period.
Both the younger and middle-aged adults showed similar patterns of muscle damage, as
reflected by the comparable myoglobin and CK responses from the exercise protocol. Elevations
in myoglobin and creatine kinase concentrations in both groups are consistent with the expected
physiological response from high volume exercise (Clarkson et al., 2006; Sayers & Clarkson,
2003). Considering the similar training background (e.g. recreational) of these subjects, these
results are not surprising. These results also suggest that middle-aged recreationally active men
who regularly engage in resistance training are not at greater risk for either muscle soreness or
muscle damage in comparison to younger recreationally trained adults.
No significant elevations from BL were observed in either C-reactive protein or IL-6
concentrations for either group. This again is likely related to the recreational training status of
both groups. Previous research has reported that regular exercise can attenuate the C-reactive
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protein response (Kasapis et al., 2005; Toft et al., 2002). IL-6 has generally been reported to
increase following acute exercise (Kasapis et al., 2005; Pedersen & Febbraio, 2005). Although
no significant elevations were observed in the IL-6 response, a trend towards an increase was
detected. Considering the participants were at least 10 hours fasted before the initial exercise
protocol, although speculative, a reduction of muscle glycogen may have influenced the IL-6
response. Muscle glycogen depletion has been reported to upregulate IL-6 transcription
(Steensberg et al., 2001).
No differences in subjective levels of pain or soreness were observed between the groups.
The results regarding subjective feelings of pain are consistent with the inflammatory response
observed, while the elevations observed in subjective feelings of soreness is supportive of the
pattern of response observed in the muscle damage markers. The significant increase in muscle
soreness through 48H, accompanied by elevated markers of muscle damage (i.e. myoglobin,
creatine kinase) is consistent with other studies assessing muscle damage from an acute exercise
bout (Jajtner et al., 2015; Kanda et al., 2013). The CRP concentrations in the current
investigation remained unchanged, which is consistent with other investigations of recreationally
experienced subjects (Croisier et al., 1999; Jajtner et al., 2015). However, in contrast to the
current findings, Jajtner and colleagues (2015) reported significant elevations in IL-6; these
differences may be related to differences in the exercise intervention or muscle mass utilized.
Conclusions
This investigation sought to compare the changes in the recovery response from a highvolume intervention among younger and middle-aged men. Although participants from each
group displayed baseline differences in isometric average torque and rapid force production, age
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did not influence the ability to recover from a damaging high-volume isokinetic protocol
between younger and middle-aged men. There was not a pronounced physiological difference
observed in the recovery response in the groups studied in this investigation, however previous
research has shown differences in recovery with age groups different from the current research
(e.g. younger to older adults; middle-aged to older adults). Furthermore, age may not
significantly affect the recovery response from exercise in mid-life, but may become a primary
factor in older age. Age also may be more of a factor in recovery depending on the muscle mass
utilized, as well as the intensity and volume of exercise. Results of this study seem to suggest
that there may be other primary contributing factors to the rate of recovery from exercise beyond
an individual’s chronological age (e.g. training status) during mid-life.
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